Fonte: Anti-Cancer Drugs. Unidade: FMRP
Assuntos: OSTEOSSARCOMA (TRATAMENTO;EFEITOS DE DROGAS), NEOPLASIAS ÓSSEAS, APOPTOSE, QUIMIOTERÁPICOS (COMBINAÇÃO), ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO-GAMERO, Angel Mauricio et al. Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells. Anti-Cancer Drugs, v. 23, n. 6, 2012Tradução . . Disponível em: https://doi.org/10.1097/CAD.0b013e328350e835. Acesso em: 01 nov. 2024.APA
Castro-Gamero, A. M., Borges, K. S., Silveira, V. da S., Lira, R. C. P., Queiroz, R. G. de P., Valera, F. C. P., et al. (2012). Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells. Anti-Cancer Drugs, 23( 6). doi:10.1097/CAD.0b013e328350e835NLM
Castro-Gamero AM, Borges KS, Silveira V da S, Lira RCP, Queiroz RG de P, Valera FCP, Scrideli CA, Umezawa K, Tone LG. Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells [Internet]. Anti-Cancer Drugs. 2012 ; 23( 6):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1097/CAD.0b013e328350e835Vancouver
Castro-Gamero AM, Borges KS, Silveira V da S, Lira RCP, Queiroz RG de P, Valera FCP, Scrideli CA, Umezawa K, Tone LG. Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells [Internet]. Anti-Cancer Drugs. 2012 ; 23( 6):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1097/CAD.0b013e328350e835
